Stryker Stock Boosted by Big Money Investors

Lucas Downey
Published: Apr 5, 2024, 20:42 GMT+00:00

Stryker Corporation (SYK) shares are up 16% year-to-date. Medical procedures and investor demand for medical technology companies have boosted volumes.

USA, New York, Wall Street. FX Empire

In this article:

Stryker Shares are Under Heavy Accumulation

Institutional volumes reveal plenty. In the last year, SYK has enjoyed heavy Big Money buying, which we believe to be institutional accumulation.

Each of the green bars signal unusually large volumes in SYK shares, pushing the stock higher:


Plenty of health care names are under accumulation right now. But when you dive into the fundamentals, there’s a special tailwind going on with Stryker.

Stryker Fundamental Analysis

Institutional support coupled with a healthy fundamental backdrop makes this company worth investigating. As you can see, SYK has had positive sales and EPS growth in recent years:

  • 3-year sales growth rate (+12.7%)
  • 3-year EPS growth rate (+25.3%)

Source: FactSet

The one-year EPS outlook is estimated to increase by +12.1%.

Now it makes sense why the stock has been powering to new heights. SYK is gaining due to its strong earnings performance.

Marrying great fundamentals with our proprietary software has found some big winning stocks over the long term.

SYK has recently been a top-rated stock at MAPsignals. That means the stock has unusual buy pressure and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis.

It’s made the rare Top 20 report numerous times. The blue bars below show when SYK was a top pick cutting through the noise.


Tracking unusual volumes reveals the power of money flows.

This is a trait that most outlier stocks exhibit. Today’s money flows often reveal tomorrow’s leaders.

Stryker Price Prediction

The SYK rally isn’t new at all. Big Money buying in the shares is signaling to take notice. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a diversified portfolio.

Disclosure: the author holds no position in SYK at the time of publication.

If you are a Registered Investment Advisor (RIA) or a serious investor looking to take your investing to the next level, learn more about the MAPsignals process here.

About the Author

Lucas Downeycontributor

Lucas is a well-versed equity investor and educator. He currently is co-founder of research and analytics firm,, which focuses on finding outlier stocks by following the Big Money.

Did you find this article useful?